Recent news on Gemcitabine Hcl

Making Science Personal: Lilly  -  May 22, 2007
Ad-Hoc-News (Pressemitteilung),The company will present important data on GEMZAR(R) (gemcitabine HCl for injection), ALIMTA(R) (pemetrexed for injection), and enzastaurin,

Lilly Oncology Focused on Pharmacogenomics at AACR Annual Meeting  -  Apr 17, 2007
Drug Newswire (press release),Many of the studies -- which investigate ALIMTA(R) (pemetrexed for injection); GEMZAR(R) (gemcitabine HCl for injection), enzastaurin and other products in

Pro-Pharmaceuticals Collaborates with Chemwerth to Scale-up ...  -  Feb 20, 2007
PharmaLive.com (press release),Etoposide USP, Fludarabine Phosphate, Gemcitabine HCl USP, Ifosfamide USP, Irinotecan HCl 3H2O, Mitoxantrone HCl USP/PhEur and Thiotepa USP.

SMS Pharma to invest Rs 1130.20 mn for expansion  -  Feb 8, 2007
Myiris.com,Sildenafil Citrate, Omeprazole Magnesium, Ramipril, Almotriptan maleate, Gemcitabine HCl, Imatinib Mesilate and their intermediates.

Pharma Sector: Few Newsmakers Of The Week - Schwarz Pharma ...  -  Jan 6, 2007
Trading Markets,In July last year the FDA approved gemcitabine HCl, known as Gemzar, in chemotherapy cancer treatments for women facing recurrent ovarian cancer.

MethylGene Announces Third Quarter 2006 Results  Nov 1, 2006
In October, we announced the initiation of a Phase I/II trial in combination with Gemzar(R) (gemcitabine HCl, Eli Lilly and Company) in pancreatic cancer ... -Therapeutics Daily (subscription) (press release), Pharmion Corporation Initiates Phase One/Two Combination Clinical ...  Oct 26, 2006
...evaluating its class I-specific histone deacetylase (HDAC) inhibitor product candidate, MGCD0103, in combination with Gemzar(R) (gemcitabine HCl; Eli Lilly and ... -PipelineReview.com (press release), MethylGene Announces Third Quarter 2006 Results  Nov 1, 2006
In October, we announced the initiation of a Phase I/II trial in combination with Gemzar ® (gemcitabine HCl, Eli Lilly and Company) in pancreatic cancer ... -CCNMatthews (press release), MethylGene Announces Third Quarter 2006 Results  Nov 1, 2006
In October, we announced the initiation of a Phase I/II trial in combination with Gemzar® (gemcitabine HCl, Eli Lilly and Company) in pancreatic cancer (Trial ... -Market Wire (press release) Enzon Pharmaceuticals Announces Advancements in Its Oncology ...  Aug 1, 2006
...to assess its safety and potential utility in the treatment of advanced solid tumors and lymphomas in combination with Gemzar(R) (gemcitabine HCl for Injection ... -PipelineReview.com

Enzon Reports Second Quarter 2006 Results; Company Continues to ...  Aug 1, 2006
...two updates from its oncology pipeline; first, the start of a phase I trial with Oncaspar(R) in combination with Gemzar(R) (gemcitabine HCl for Injection) in ... -Finanzen.net

FDA Approvals: Emend, Gemzar, Avastin  Jul 21, 2006
...and Drug Administration (FDA) has approved aprepitant capsules for use in preventing postoperative nausea and vomiting; use of gemcitabine HCl injection in ... -Medscape (subscription)

FDA Approves Lilly's Gemzar (Gemcitabine HCl) for Ovarian Cancer ...  Jul 17, 2006
17, 2006 -- Today, Eli Lilly and Company announced that the United States Food and Drug Administration (FDA) has approved Gemzar(R) (gemcitabine HCl) for use ... -DG News

FDA Approves Lilly's Gemzar® For Ovarian Cancer Treatment  Jul 19, 2006
Eli Lilly and Company recently announced that the FDA has approved GEMZAR® (gemcitabine HCl) for use in the treatment of women living with recurrent ovarian ... -Pharmaceutical Processing

International Approvals: NuvaRing, MabThera, Gemzar  Jul 17, 2006
...rheumatoid arthritis in adults; and Japan's Ministry of Health, Labor, and Welfare has approved a new indication for gemcitabine HCl injection, allowing its ... -Medscape (subscription)

FDA Approves Lilly's Gemzar For Ovarian Cancer Treatment  Jul 18, 2006
Eli Lilly and Company announced that the United States Food and Drug Administration (FDA) has approved GEMZAR (gemcitabine HCl) for use in the treatment of ... -Playfuls.com

FDA Approves Lilly's Gemzar(R) For Ovarian Cancer Treatment  Jul 20, 2006
Today, Eli Lilly and Company announced that the United States Food and Drug Administration (FDA) has approved GEMZAR® (gemcitabine HCl) for use in the ... -dBusinessNews Indianapolis

Lilly's Gemzar Receives FDA Approval For Recurrent Ovarian Cancer  Jul 17, 2006
Today, Eli Lilly and Company (NYSE: LLY) announced that the United States Food and Drug Administration (FDA) has approved GEMZAR (gemcitabine HCl) for use in ... -Inside INdiana Business



Lilly Launches Phase III Trial of Targeted Cancer Agent  Mar 9, 2006
Alimta(R) (pemetrexed, Eli Lilly and Company) Gemzar(R) (gemcitabine HCl, Eli Lilly and Company) CeeNU(R) (lomustine [CCNU], Bristol Myers Squibb) (Logo: http ... - news aktuell (Pressemitteilung)

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional